And that is my opinion reading the report and also my current knowledge of the Relenza story.
The Ribena story was a good lesson for any company that even two young girls from NZ can bring a multinational company in court and make them lose the case.
Biota will be another winner , just how long its going to take that will be the biggest question not if it will happen.
The smartest thing that BTA was the capital raising to make sure that they had the funds to go all the way in this courtcase.
In the meantime Relenza sales will make sure that this live line will continue and GSK will be pushed more and more into a corner with lots of unwanted Media reports putting GSK in the spotlight.
An out of court settlement will be the best option for GSK and this is going to happen imho.
As we can see on the ASX announcements the directors of BTA have given their vote in this case, and its backed all the way with their own cash.
Good luck to all
And in the meantime I make sure that I will keep a nice parcel of BTA to reap some of the lost benefits, once an deal has been made.
jojo
BTA Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
